Virginia sickle cell advocates prepare legislative push as Del. Candi Mundon King continues fight months after losing ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
The Kenya Times on MSN
I was diagnosed at 3 months, sickle cell warrior Ekaya Duncan shares lifelong battle with the condition
Ekaya Duncan, 24, CEO of Mainplug TV and a sickle cell warrior, explains that his journey with the condition began in infancy ...
Higher levels of fetal hemoglobin may guard against lung problems and delay bone damage in people with sickle cell disease, ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...
As of Tuesday, January 06, Beam Therapeutics Inc.’s BEAM share price has surged by 9.20%, which has investors questioning if ...
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...
Morning Overview on MSN
New CRISPR leap could transform treatment for genetic diseases
Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...
A total of 2,086 children were screened for anaemia and 499 for pneumonia, while 1,165 children were vaccinated against preventable diseases du.
Balance Sheet and Sharpened Strategy VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 8, 2026 / Lobe Sciences Ltd. ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback